myAbbVie Assist: Qulipta, Ubrelvy

Funded
About
The myAbbVie Assist: Qulipta, Ubrelvy program offers substantial benefits for patients in need of Ubrelvy and Qulipta medications. This program is designed to assist individuals with limited or no health insurance coverage in accessing these critical drugs. Through the myAbbVie Assist program, eligible patients residing in the U.S. may receive their medication free of charge, ensuring they continue to manage their health effectively despite financial constraints.
Insurance requirements: Medicare / Medicaid, Underinsured, Uninsured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Eligible patients may be able to receive medication free of charge
Completed AbbVie Patient Assistance Program forms should be signed by their HCP and faxed to: 8662502803
Completed AbbVie PAP forms can also be mailed to: AbbVie Patient Access Support D617927 AP5 NE, 1 N. Waukegan Rd. North Chicago, Il 60064
For assistance or additional information, call 8002226885, Monday Friday
Other Programs

HealthWell: Migraine

Commercially Insured
Medicare / Medicaid
Max Saving: $4000/year*

PAF Co-Pay Relief: Migraine

Medicare / Medicaid
Max Saving: $2000/year*
Other Tools for Ubrelvy